https://news.vrtx.com/news-releases/news-release-details/vertex-announces-positive-results-phase-2-study-vx-548-treatment
0
0
Vertex Announces Positive Results From Phase 2 Study of VX-548 for the Treatment of Painful Diabetic Peripheral Neuropathy | Vertex Pharmaceuticals Newsroom - Vertex Pharmaceuticals
12/13/23 at 11:53am
Organization
Vrtx.com
Create an account or login to join the discussion